Search Results 1651-1660 of 20476 for hepatitis

  1. A Phase 1/​2 Study of STP938 for Adult Subjects With Relapsed/​Refractory B-Cell and T-Cell Lymphomas - Mayo Clinic

    - Known active or chronic hepatitis B or active hepatitis C virus (HCV) infection. - Subjects who have received a live vaccine within 30 days prior to study ...

  2. A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) (Morpheus-Gastric Cancer) - Mayo Clinic

    Active hepatitis B virus (HBV) or hepatitis C (HCV) infection;; Severe infection within 4 weeks prior to initiation of study treatment;; Significant ...

  3. Effectiveness and Safety of Pembrolizumab for Participants with Resectable Stage IIB or IIIA Non-small Cell Lung Cancer - Mayo Clinic

    Has a known history of Hepatitis B or Hepatitis C. Has a known history of active tuberculosis. Has a history or current evidence of any condition, therapy ...

  4. Surgery - Doctors - Mayo Clinic

    Hepatitis C, Hepatitis B, Hepatocellular carcinoma, Nonalcoholic fatty liver disease, Cirrhosis, Alcoholic hepatitis, H...epatic encephalopathy, Portal ...

  5. A Study of TRK-950 in Patients With Advanced Solid Tumors - Mayo Clinic

    Known active infection with HIV, hepatitis B, hepatitis C. Symptomatic brain metastases. Patients with asymptomatic brain metastases may be enrolled ...

  6. ... HEPATITIS WITH MCC,48664.82 MS433,CIRRHOSIS AND ALCOHOLIC HEPATITIS WITH CC,20935.29 MS435,MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH MCC,41420.34 ...

  7. HIV/AIDS - Symptoms and causes - Mayo Clinic

    If you have hepatitis B, you should see an infectious disease or liver specialist before beginning PrEP therapy. Use treatment as prevention, also called TasP.

  8. Kymberly D. Watt, M.D. - Doctors and Medical Staff - Mayo Clinic

    Autoimmune hepatitis; Chronic liver disease; Cirrhosis · Hepatic encephalopathy ... Post-liver transplant care. Interests. Liver transplantation; Advanced liver ...

  9. A Study Of ATR-101 For The Treatment Of Cushing’s Syndrome - Mayo Clinic

    HIV, hepatitis B, or hepatitis C positivity at screening; Any malignancy within the previous 10 years, other than curatively resected basal or squamous cell ...

  10. Study to Investigate the Safety, Pharmacokinetic Profiles and the Efficacy of Tinostamustine, a First-in-Class Alkylating Histone Deacetylase Inhibition Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies - Mayo Clinic

    ... Hepatitis B or Hepatitis C; Chemotherapy, radiotherapy, biologics, and/or other treatment with immunotherapy not completed four (4) weeks prior to first dose ...